glp-1 and colonoscopy weight-loss meds could interfere with endoscopy, Is a patient with a
Description
Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, et al
Many adults with ADHD use both safely under medical supervision
The findings from this review suggest that semaglutide induces a weight reduction of approximately 12% every 10 weeks in patients with T2DM and is more effective than other GLP-1 RAs, with the exception of tirzepatide, which is more efficacious
Long-term data continues accumulating, and no significant new safety signals have emerged with broader use
Interested in advocating for people living with T1D
